Promarc Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Nagpur, Maharashtra, India, established in 2021.
2021 Nagpur, Maharashtra, India Active
Last Updated:
Access Report
About Promarc Pharmaceuticals Private Limited

Promarc Pharmaceuticals Private Limited, a active private limited company, was established on 01 June 2021 in Nagpur, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24239MH2021PTC361396. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

Its leadership includes Girish Damodar Kalamkar (Director), Mayuresh Dilip Katyayan (Director). Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Shree Apartment Plot No. 433, G-1, Gorepeth, Dharampeth,, Nagpur, Maharashtra, 440010.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239MH2021PTC361396

  • Registration Number

    361396

  • Incorporation Date

    01 June 2021

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 4 Year, 9 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Promarc Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Promarc Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Promarc Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Girish Damodar Kalamkar Director 01 Jun 2021 Current
Mayuresh Dilip Katyayan Director 01 Jun 2021 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Promarc Pharmaceuticals.

Enhance accessibility to Promarc Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Promarc Pharmaceuticals revenue growth over time
Promarc Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Promarc Pharmaceuticals?

Unlock access to Promarc Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Promarc Pharmaceuticals?

Promarc Pharmaceuticals has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Promarc Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Promarc Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Promarc Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    The activity Promarc Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    The activity Promarc Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was completed.

  • Director Appointment

    Progress on Girish Damodar Kalamkar was appointed as a Director was appointed as a Director on 01 Jun 2021 & has been associated with this company since 4 years 9 months . was documented.

  • Director Appointment

    Progress on Mayuresh Dilip Katyayan was appointed as a Director was appointed as a Director on 01 Jun 2021 & has been associated with this company since 4 years 9 months . was documented.

  • Company Incorporation

    The activity Promarc Pharmaceuticals Private Limited was registered on 01 Jun 2021 with Roc Mumbai & aged 4 years 9 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Promarc Pharmaceuticals Private Limited?

The CIN of Promarc Pharmaceuticals Private Limited is U24239MH2021PTC361396.

Where is Promarc Pharmaceuticals Private Limited headquartered?

Promarc Pharmaceuticals Private Limited is headquartered at Shree Apartment Plot No. 433, G-1, Gorepeth, Dharampeth,, Nagpur, Maharashtra, 440010.

When was Promarc Pharmaceuticals Private Limited incorporated?

Promarc Pharmaceuticals Private Limited was incorporated on 01 June 2021.

Who are the current directors of Promarc Pharmaceuticals Private Limited?

The current directors of Promarc Pharmaceuticals Private Limited are

What is the primary industry of Promarc Pharmaceuticals Private Limited?

The primary industry of Promarc Pharmaceuticals Private Limited is Pharma.

Is Promarc Pharmaceuticals Private Limited a listed company?

Promarc Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Promarc Pharmaceuticals Private Limited?

The authorized capital of Promarc Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available